| Literature DB >> 32224891 |
Filipe Vieira Santos de Abreu1,2, Anielly Ferreira-de-Brito1, Adriana de Souza Azevedo3, José Henrique Rezende Linhares3, Vanessa de Oliveira Santos3, Emily Hime Miranda3, Maycon Sebastião Alberto Santos Neves1, Lena Yousfi4, Ieda Pereira Ribeiro5, Alexandre Araújo Cunha Dos Santos5, Edmilson Dos Santos6, Taissa Pereira Dos Santos7, Danilo Simonini Teixeira8, Marcelo Quintela Gomes1, Camilla Bayma Fernandes9, Andrea Marques Vieira da Silva9, Monique da Rocha Queiroz Lima10, Christophe Paupy7, Alessandro Pecego Martins Romano11, Ana Paula Dinis Ano Bom9, Luzia Maria de Oliveira-Pinto10, Sara Moutailler4, Monique de Albuquerque Motta1, Márcia Gonçalves Castro1, Myrna Cristina Bonaldo5, Sheila Maria Barbosa de Lima3, Ricardo Lourenço-de-Oliveira1.
Abstract
In the last decade, Flaviviruses such as yellow fever (YFV) and Zika (ZIKV) have expanded their transmission areas. These viruses originated in Africa, where they exhibit both sylvatic and interhuman transmission cycles. In Brazil, the risk of YFV urbanization has grown, with the sylvatic transmission approaching the most densely populated metropolis, while concern about ZIKV spillback to a sylvatic cycle has risen. To investigate these health threats, we carried out extensive collections and arbovirus screening of 144 free-living, non-human primates (NHPs) and 5219 mosquitoes before, during, and after ZIKV and YFV outbreaks (2015-2018) in southeast Brazil. ZIKV infection was not detected in any NHP collected at any time. In contrast, current and previous YFV infections were detected in NHPs sampled between 2017 and 2018, but not before the onset of the YFV outbreak. Mosquito pools screened by high-throughput PCR were positive for YFV when captured in the wild and during the YFV outbreak, but were negative for 94 other arboviruses, including ZIKV, regardless of the time of collection. In conclusion, there was no evidence of YFV transmission in coastal southeast Brazil before the current outbreak, nor the spread or establishment of an independent sylvatic cycle of ZIKV or urban Aedes aegypti transmission of YFV in the region. In view of the region's receptivity and vulnerability to arbovirus transmission, surveillance of NHPs and mosquitoes should be strengthened and continuous.Entities:
Keywords: Flavivirus; PRNT; arboviruses; high throughput real time PCR; serology
Mesh:
Year: 2020 PMID: 32224891 PMCID: PMC7232473 DOI: 10.3390/v12040364
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Figure 1Number of human cases of Zika virus (ZIKV) and Yellow Fever virus (YFV) registered in Brazilian Southeast between 2014 and 2019 (https://www.saude.gov.br/boletins-epidemiologicos). In 2015, the year of the emergence of ZIKV in Brazil, there were no specific diagnostic and notification protocols. Therefore, the number of ZIKV cases showed in 2015 is an estimate for Brazilian Southeast, based in the conservative number of 440,000 cases in Brazil, in 2015, predicted by Helkeubach et al. (2016) [21].
Figure 2Satellite image showing mosquito and non-human primate (NHP) collection points. The number of NHPs captured is proportional to the size of the circle. Empty squares indicate areas where we attempt to capture NHPs without success.
Figure 3Number of examined and positive non-human primates and mosquitoes, according to epidemiological scenario, semester, year and diagnosis methods. Results of mosquito infections (*) are expressed in number of positive pools.
Mosquito species collected and screened through 94 arbovirus genotypes in four Brazilian states: Espírito Santo (ES), Minas Gerais (MG), Rio de Janeiro (RJ) and São Paulo (SP).
| Species Per Year / Semester | Number | Date | Counties (State) | Result PCR |
|---|---|---|---|---|
|
| 4 | 2015/1 |
| Neg. |
|
| 12 | 2015/1 | Neg. | |
|
| 1 | 2015/1 | Neg. | |
|
| 17 | 2015/1 | Neg. | |
|
| 2 | 2015/1 | Neg. | |
|
| 10 | 2015/1 | Neg. | |
|
| 5 | 2015/1 | Neg. | |
|
| 1 | 2015/1 | Neg. | |
|
| 1 | 2015/1 | Neg. | |
|
| 1 | 2015/1 | Neg. | |
|
| 1 | 2015/1 | Neg. | |
|
| 89 | 2015/1 | Neg. | |
|
| 4 | 2015/1 | Neg. | |
|
|
| Neg. | ||
|
| 14 | 2015/2 |
| Neg. |
|
| 1 | 2015/2 | Neg. | |
|
| 94 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 25 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 3 | 2015/2 | Neg. | |
|
| 9 | 2015/2 | Neg. | |
|
| 10 | 2015/2 | Neg. | |
|
| 60 | 2015/2 | Neg. | |
|
| 87 | 2015/2 | Neg. | |
|
| 26 | 2015/2 | Neg. | |
|
| 2 | 2015/2 | Neg. | |
|
| 41 | 2015/2 | Neg. | |
|
| 21 | 2015/2 | Neg. | |
|
| 3 | 2015/2 | Neg. | |
|
| 15 | 2015/2 | Neg. | |
|
| 8 | 2015/2 | Neg. | |
|
| 48 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 20 | 2015/2 | Neg. | |
|
| 2 | 2015/2 | Neg. | |
|
| 19 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 5 | 2015/2 | Neg. | |
|
| 2 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 2 | 2015/2 | Neg. | |
|
| 7 | 2015/2 | Neg. | |
|
| 2 | 2015/2 | Neg. | |
|
| 8 | 2015/2 | Neg. | |
|
| 49 | 2015/2 | Neg. | |
|
| 28 | 2015/2 | Neg. | |
|
| 24 | 2015/2 | Neg. | |
|
| 5 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 5 | 2015/2 | Neg. | |
|
| 1 | 2015/2 | Neg. | |
|
| 11 | 2015/2 | Neg. | |
|
| 5 | 2015/2 | Neg. | |
|
| 42 | 2015/2 | Neg. | |
|
| 4 | 2015/2 | Neg. | |
|
| 43 | 2015/2 | Neg. | |
|
| 6 | 2015/2 | Neg. | |
|
|
| Neg. | ||
|
| 1 | 2016/1 |
| Neg. |
|
| 56 | 2016/1 | Neg. | |
|
| 2 | 2016/1 | Neg. | |
|
| 44 | 2016/1 | Neg. | |
|
| 2 | 2016/1 | Neg. | |
|
| 12 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 14 | 2016/1 | Neg. | |
|
| 44 | 2016/1 | Neg. | |
|
| 7 | 2016/1 | Neg. | |
|
| 10 | 2016/1 | Neg. | |
|
| 31 | 2016/1 | Neg. | |
|
| 12 | 2016/1 | Neg. | |
|
| 30 | 2016/1 | Neg. | |
|
| 3 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 22 | 2016/1 | Neg. | |
|
| 25 | 2016/1 | Neg. | |
|
| 29 | 2016/1 | Neg. | |
|
| 4 | 2016/1 | Neg. | |
|
| 3 | 2016/1 | Neg. | |
|
| 6 | 2016/1 | Neg. | |
|
| 19 | 2016/1 | Neg. | |
|
| 5 | 2016/1 | Neg. | |
|
| 84 | 2016/1 | Neg. | |
|
| 4 | 2016/1 | Neg. | |
|
| 18 | 2016/1 | Neg. | |
|
| 5 | 2016/1 | Neg. | |
|
| 4 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 1 | 2016/1 | Neg. | |
|
| 6 | 2016/1 | Neg. | |
|
| 3 | 2016/1 | Neg. | |
|
| 8 | 2016/1 | Neg. | |
|
| 118 | 2016/1 | Neg. | |
|
| 9 | 2016/1 | Neg. | |
|
|
| Neg. | ||
|
| 9 | 2016/2 |
| Neg. |
|
| 1 | 2016/2 | Neg. | |
|
| 11 | 2016/2 | Neg. | |
|
| 4 | 2016/2 | Neg. | |
|
| 4 | 2016/2 | Neg. | |
|
| 13 | 2016/2 | Neg. | |
|
| 1 | 2016/2 | Neg. | |
|
| 8 | 2016/2 | Neg. | |
|
| 22 | 2016/2 | Neg. | |
|
| 34 | 2016/2 | Neg. | |
|
| 42 | 2016/2 | Neg. | |
|
| 8 | 2016/2 | Neg. | |
|
| 1 | 2016/2 | Neg. | |
|
| 7 | 2016/2 | Neg. | |
|
| 3 | 2016/2 | Neg. | |
|
| 13 | 2016/2 | Neg. | |
|
| 4 | 2016/2 | Neg. | |
|
| 3 | 2016/2 | Neg. | |
|
| 2 | 2016/2 | Neg. | |
|
| 3 | 2016/2 | Neg. | |
|
| 3 | 2016/2 | Neg. | |
|
| 26 | 2016/2 | Neg. | |
|
| 18 | 2016/2 | Neg. | |
|
| 9 | 2016/2 | Neg. | |
|
| 6 | 2016/2 | Neg. | |
|
| 18 | 2016/2 | Neg. | |
|
| 3 | 2016/2 | Neg. | |
|
| 1 | 2016/2 | Neg. | |
|
| 60 | 2016/2 | Neg. | |
|
| 5 | 2016/2 | Neg. | |
|
| 1 | 2016/2 | Neg. | |
|
| 2 | 2016/2 | Neg. | |
|
| 2 | 2016/2 | Neg. | |
|
| 4 | 2016/2 | Neg. | |
|
| 6 | 2016/2 | Neg. | |
|
| 11 | 2016/2 | Neg. | |
|
| 23 | 2016/2 | Neg. | |
|
| 9 | 2016/2 | Neg. | |
|
|
| Neg. | ||
|
| 94 | 2017/1 |
| Neg |
|
| 1 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 876 | 2017/1 |
| |
|
| 9 | 2017/1 | Neg. | |
|
| 892 | 2017/1 |
| |
|
| 7 | 2017/1 | Neg. | |
|
| 22 | 2017/1 | Neg. | |
|
| 4 | 2017/1 | Neg. | |
|
| 72 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 16 | 2017/1 | Neg. | |
|
| 6 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 56 | 2017/1 | Neg. | |
|
| 4 | 2017/1 | Neg. | |
|
| 103 | 2017/1 | Neg. | |
|
| 8 | 2017/1 |
| |
|
| 199 | 2017/1 |
| |
|
| 189 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 12 | 2017/1 | Neg. | |
|
| 75 | 2017/1 | Neg. | |
|
| 14 | 2017/1 | Neg. | |
|
| 10 | 2017/1 | Neg. | |
|
| 21 | 2017/1 | Neg. | |
|
| 4 | 2017/1 | Neg. | |
|
| 10 | 2017/1 | Neg. | |
|
| 13 | 2017/1 | Neg. | |
|
| 12 | 2017/1 | Neg. | |
|
| 10 | 2017/1 | Neg. | |
|
| 60 | 2017/1 | Neg. | |
|
| 194 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 4 | 2017/1 |
| |
|
| 3 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 47 | 2017/1 | Neg. | |
|
| 2 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 7 | 2017/1 | Neg. | |
|
| 3 | 2017/1 | Neg. | |
|
| 7 | 2017/1 | Neg. | |
|
| 11 | 2017/1 | Neg. | |
|
| 40 | 2017/1 | Neg. | |
|
| 9 | 2017/1 | Neg. | |
|
| 7 | 2017/1 | Neg. | |
|
| 14 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 9 | 2017/1 | Neg. | |
|
| 17 | 2017/1 | Neg. | |
|
| 4 | 2017/1 | Neg. | |
|
| 1 | 2017/1 | Neg. | |
|
| 20 | 2017/1 | Neg. | |
|
| 45 | 2017/1 | Neg. | |
|
|
| |||
|
|
|
|
|
|
a: The YFV mosquito infections revealed by the high throughput PCR were confirmed by RNA sequencing and RT-qPCR using distinct set of primers, whose results were published elsewhere [34,35]. Mosquitoes captured before ZIKV and YFV outbreaks. Mosquitoes examined during the ZIKV and before YFV outbreaks. Mosquitoes examined after ZIKV and during YFV outbreaks
List of samples that showed unspecific response during the PRNT90 assays for tested viruses.
| Non-Human Primate Data | Molecular Results | PRNT Results | ELISA Results | Conclusions | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | Species | State | Health state | rt-PCR | CT | YFV 90% | ZIKV 90% | DENV1 90% | DENV2 90% | DENV3 90% | DENV 4 90% | Serum Quality | YFV | ZIKV | DENV | Imunological | Molecular |
| RJ10 |
| RJ | Healthy | Neg. | _ | < 5 | 168.3 | 28.9 | 23.9 | 48.0 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ18 |
| RJ | Healthy | Neg. | _ | < 5 | 17.2 | <20 | < 10 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ46 |
| MG | Dying | Neg. | _ | 29.9 | 341.8 | 180.0 | <10 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ60 |
| RJ | Healthy | Neg. | _ | <10 | 10.8 | - | < 10 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ62 |
| RJ | Healthy | Neg. | _ | < 5 | 41.6 | <100 | < 10 | < 10 | < 10 | Hemoly | - | - | - | Negative | Negative |
| RJ64 |
| RJ | Healthy | Neg. | _ | < 5 | 13.1 | <100 | 14.4 | < 10 | < 10 | Hemoly | - | - | - | Negative | Negative |
| RJ87 |
| RJ | Dead | YFV | Conv. | <20 | 87.1 | <500 | < 10 | 29.5 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | YFV |
| RJ91B |
| RJ | Healthy | Neg. | _ | < 5 | 31.26 | <20 | - | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ95 |
| RJ | Dead | YFV | 11.7 | < 5 | 65.9 | 30.0 | 10.3 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | YFV |
| RJ96 |
| RJ | Dead | YFV | Conv. | <40 | 420.3 | - | >250 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | YFV |
| RJ104 |
| RJ | Dead | YFV | 13.7 | < 5 | 11.6 | - | - | - | - | Hemoly | Neg. | Neg. | Neg. | Negative | YFV |
| AR03 |
| RJ | Healthy | Neg. | _ | < 5 | 12.7 | - | - | - | - | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| RJ118 |
| RJ | Healthy | Neg. | _ | < 5 | 39.1 | - | - | - | - | Hemoly | Neg. | Neg. | Neg. | Negative | Negative |
| ES01 |
| ES | Healthy | Neg. | _ | < 5 | 14.5 | <10 | < 10 | 17.17 | < 10 | Normal | Neg. | Neg. | Neg. | Negative | Negative |
| ES04 |
| ES | Dying | YFV | Conv. | 6.9 | 85.4 | - | 24.51 | < 10 | < 10 | Hemoly | Neg. | Neg. | Neg. | Negative | YFV |
“-“ means that it was not possible to perform the test due to sample exhaustion; + : indicate the degree of hemolysis; conv: conventional RT-PCR; *: hybrids of C. jacchus and C. penicillata. NHPs examined during Zika (ZIKV) and before Yellow Fever (YFV) outbreaks. NHPs examined after ZIKV and during YFV outbreaks.